Pre-Application Webinars for RFA-CA-20-047, Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Notice Number:

Key Dates

Release Date:

September 3, 2020

Related Announcements

RFA-CA-20-047 - Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Issued by

National Cancer Institute (NCI)


The NCI will hold two pre-application webinars for the “Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required).” The intent of the webinars is to provide an overview of the initiative (RFA-CA-20-047) and to address questions pertinent to preparing applications. The webinars are optional and not required for application submission.

Webinar Dates and required pre-registration:

To attend on Monday Sept. 21, 3:00-4:00 PM EDT, register here

To attend on Wednesday Sept. 30, 2:00-3:00 PM EDT, register here

Please submit questions in advance, no later than September 16 for the September 21 webinar or no later than September 25 for the September 30 webinar, to Suzanne Forry, Please indicate “GTN RFA webinar” in the subject line of your email; the email should include which webinar you plan to attend. Attendees will also be able to submit questions during the webinar. Questions submitted in advance will be answered first.

Following the webinar, attendees and prospective applicants who were unable to participate in the webinar may request a copy of the webinar slides and a summary of questions and answers.


Please direct all inquiries to:

Suzanne Forry, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5922

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices